Alzheimer’s Drug Discovery Foundation Honors Lauder Family in Recognition of $200M Gift

Christine Schott Ledes — Fri, 10 Nov 2023 16:19:49 +0000

The Alzheimer’s Drug Discovery Foundation (ADDF) hosted their Sixteenth Annual Connoisseur’s Dinner, honoring Leonard A. Lauder, Ronald S. Lauder, William Lauder, Gary Lauder, Aerin Lauder Zinterhofer, and Jane Lauder in celebration of their historic $200 million gift to the ADDF, announced earlier this year.

The event, held at Sotheby’s in New York City, raised nearly $3 million, every dollar of which will go directly toward the innovative science that fuels the ADDF’s mission to accelerate the development of drugs to prevent, treat, and cure Alzheimer’s disease. The Lauders’ extraordinary gift ensures the ADDF will be able to continue our work until we have fulfilled our goal, ultimately changing the way the world ages.

Aerin Lauder, Lori Kanter Tritsch, Danielle Lauder, William P. Lauder, Rachel Lauder, Jane Lauder, Ronald S. Lauder, Jo Carole Lauder, Gary M. Lauder, Laura Lauder

Celebrated author and journalist Walter Isaacson presented the Lauder family with the Chairman’s Award. “Since Leonard and Ronald Lauder founded the ADDF 25 years ago, the family has shown an unmatched dedication to curing this devastating disease, infusing the Lauder spirit of innovation, quality, and excellence into the ADDF’s quest to identify and support the most promising research. It is an honor to recognize their efforts tonight.”

Leonard Lauder said, “Alzheimer’s disease doesn’t affect just one person, it impacts entire families. That is why it is so meaningful for my family to be honored by the ADDF, an organization my brother and I began because of our mother. She inspired us to do everything we could to fight and prevent this disease and I am proud to see my children and nieces pick up that torch.”

Ronald Lauder added, “We are proud of the impact the ADDF has made over the past two decades. The progress we are seeing in prevention, diagnostics, and drug development makes me confident the innovative research we support will continue to build momentum until we eradicate this disease for future generations.”

The ADDF’s Co-Founder and Chief Science Officer Dr. Howard Fillit remarked on the incredible progress of the past year and the ADDF’s plan to continue this momentum. “There has never been a more exciting time in Alzheimer’s research, and we would not be here without the vision, commitment, and leadership of the Lauder family. Their remarkable gift comes at a critical time, with a new era dawning in the field and the ADDF leading the charge to build upon recent breakthroughs. Our laser focus on a precision medicine and combination therapy approach will revolutionize treatment and stop Alzheimer’s in its tracks.”

The black-tie event featured an exclusive preview of Sotheby’s Impressionist, Modern, and Contemporary Art sales and wine pairings presented by Sotheby’s Wine.

Notable guests included:Jo Carole Lauder, Laura Lauder, Danielle Lauder, Rachel Lauder-Lyons, Lori Kanter-Tritsch, Fabrizio Freda, Karen Lauder, Nancy Goodes, Jane Hertzmark Hudis, Walter Isaacson, Bonnie Lautenberg, Heidi and Tom McWilliams, Ann Tisch, Barbara Tober, Paula Zahn, Ginger and Larry Leeds, Hilary and Wilbur Ross, Eleanora Kennedy, Sharon Loeb and John Paulson and Alina de Almeida.

The post Alzheimer’s Drug Discovery Foundation Honors Lauder Family in Recognition of $200M Gift appeared first on The Beauty Influencers.

ELC and Lauder Family Further Commitment to Eliminating Breast Cancer Disparities

Christine Schott Ledes — Fri, 28 May 2021 12:16:16 +0000

To reinforce and build upon The Estée Lauder Companies’ (ELC) legacy of breast cancer funding and furthering the company’s commitment to Racial Equity, the company and the Lauder Family will invest $1 million over two years towards research to help eliminate breast cancer disparities. Through grants with the Breast Cancer Research Foundation (BCRF), two important new initiatives will be supported.

The first grant will support Dr. Nikhil Wagle of Dana-Farber Cancer Institute and will aim to both improve our understanding of metastatic breast cancer in Black patients and expand the participation of Black breast cancer patients in clinical research. By studying the progression of disease and response to therapies specifically in Black patients, Dr. Wagle’s work is expected to help lead to targeted therapies, precision medicine and improved outcomes specifically for Black patients.

Through work in partnership with the American Society of Clinical Oncology and the American Association of Cancer Research, the second grant will support a new directive through BCRF to provide funding to early-career, under-represented investigators in the breast cancer research field, or research aimed at breast cancer disparities. This work is expected to have a significant impact on the career development for early-stage investigators at a critical juncture in their career path.

It’s #TimeToEndBreastCancer.

The post ELC and Lauder Family Further Commitment to Eliminating Breast Cancer Disparities appeared first on The Beauty Influencers.

LauderFamily – The Beauty Influencers

Alzheimer’s Drug Discovery Foundation Honors Lauder Family in Recognition of $200M Gift

ELC and Lauder Family Further Commitment to Eliminating Breast Cancer Disparities